VaxSyna Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.7M

  • Investors
  • 4

VaxSyna General Information

Description

Operator of a vaccine and antibody therapeutic development company intended to combat various pathogens associated with global health challenges. The company develops a vaccine platform with multiple antigen display for pathogenic diseases, cancer, pandemic threats, emerging diseases, disseminated pathogens, and widely prevalent diseases, enabling the medical industry to get improved and easy access to vaccines.

Contact Information

Website
www.vaxsyna.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 45 Circle
  • Franklin, NH 03235
  • United States
+1 (603)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences, Oncology
Corporate Office
  • 45 Circle
  • Franklin, NH 03235
  • United States
+1 (603)

VaxSyna Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VaxSyna Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Aug-2023 $1.7M Completed Pre-Clinical Trials
5. Early Stage VC 16-Jul-2022 Completed Pre-Clinical Trials
4. Grant 01-Apr-2022 Completed Pre-Clinical Trials
3. Early Stage VC 20-Jan-2022 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view VaxSyna’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

VaxSyna Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a vaccine and antibody therapeutic development company intended to combat various pathogens associated with
Drug Discovery
Franklin, NH
5 As of 2025

Mountain View, CA
 

San Carlos, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VaxSyna Competitors (2)

One of VaxSyna’s 2 competitors is IGM Biosciences, a Formerly VC-backed company based in Mountain View, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IGM Biosciences Formerly VC-backed Mountain View, CA
Vaxcyte Formerly VC-backed San Carlos, CA
You’re viewing 2 of 2 competitors. Get the full list »

VaxSyna Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VaxSyna Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Congressionally Directed Medical Research Programs Government
Skysong Innovations Accelerator/Incubator
Center for Entrepreneurial Innovation Accelerator/Incubator
Yoo & Co Accelerator Accelerator/Incubator
To view VaxSyna’s complete investors history, request access »

Ready to get started?

Request a free trial

VaxSyna FAQs

  • When was VaxSyna founded?

    VaxSyna was founded in 2020.

  • Where is VaxSyna headquartered?

    VaxSyna is headquartered in Franklin, NH.

  • What is the size of VaxSyna?

    VaxSyna has 5 total employees.

  • What industry is VaxSyna in?

    VaxSyna’s primary industry is Drug Discovery.

  • Is VaxSyna a private or public company?

    VaxSyna is a Private company.

  • What is VaxSyna’s current revenue?

    The current revenue for VaxSyna is .

  • How much funding has VaxSyna raised over time?

    VaxSyna has raised $25K.

  • Who are VaxSyna’s investors?

    Congressionally Directed Medical Research Programs, Skysong Innovations, Center for Entrepreneurial Innovation, and Yoo & Co Accelerator have invested in VaxSyna.

  • Who are VaxSyna’s competitors?

    IGM Biosciences and Vaxcyte are competitors of VaxSyna.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »